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contributed to the smaller difference in peak VO2 between diabetics
and nondiabetics in the Guazzi et al. (5) study. Glycosylated
hemoglobin was7% in every one of the Guazzi et al. (5) patients,
whereas it averaged 7.5% in our patients. Insulin therapy improves
peak VO2 in patients with diabetes and CHF (6,7). Diabetes is
associated with cardiac, vascular, metabolic, and skeletal muscle
alterations that all tend to reduce peak VO2 (8). High-energy
phosphate metabolism is impaired in skeletal muscles from pa-
tients with diabetes in the absence of CAD or LV dysfunction (2).
Phosphocreatinine loss, pH decline, and deoxygenation occur
sooner in exercising skeletal muscles of diabetics than in controls.
Alterations in energy metabolism contribute to reduce peak aerobic
capacity in CHF (9,10). The coexistence of diabetes and CHF may
further alter skeletal muscle energy metabolism and reduce peak
aerobic capacity. A major limitation of our study is the absence of
longitudinal data with tighter diabetes control.
In summary, diabetes negatively impacts on and is an indepen-
dent determinant of peak aerobic capacity in patients with CHF.
Diabetes needs to be taken into consideration when evaluating
functional capacity in patients with CHF.
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Left Ventricular Wall Motion Abnormalities Induced by Squatting:
A New Echocardiographic Stress Test for the Diagnosis of Coronary Artery Disease
To the Editor: Stress echocardiography is useful for diagnosing
coronary artery disease (CAD) (1,2). Expense, potential for com-
plications, and the time factor are potential disadvantages of these
techniques. Thus, there is a need for a simple, inexpensive, rapid,
and safe echocardiographic stress test.
Squatting increases left ventricular afterload and preload (3–5).
This study tested the hypothesis that squatting will produce left
ventricular wall motion abnormalities (WMA) in patients with
CAD.
The study population consisted of 15 normal male subjects
(group 1) (age range 34 to 75 years, mean 57 years) and 42 male
patients (mean age 63 years, range 31 to 84 years) who had
coronary angiography (group 2). The institutional committee on
human research approved the study protocol. Informed consent
was obtained from all subjects.
The standing (3 min of quiet standing) heart rate and blood
pressure were recorded. Parasternal long- and short-axis and apical
four-, two-, and three-chamber views were obtained in the
standing position. The subjects were asked to squat, for 2 min.
Blood pressure, heart rate, and echocardiograms were recorded.
The echocardiogram was repeated after standing.
A 16-segment model was used for analysis of echocardiographic
Figure 1. Individual peak oxygen uptake (peak VO2) values in diabetic
(DM) and nondiabetic (N-DM) patients with chronic heart failure due to
left ventricular systolic dysfunction. Mean peak VO2 is significantly lower in
DM than in N-DM patients.
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images. A squatting stress echocardiogram was considered positive
if there was a new or worsening WMA during squatting. An
isolated fixed WMA was not considered a positive result. A
stenosis of 50% or greater was considered significant.
Continuous variables are presented as mean and standard
deviation and were compared using the Student t test. A p value of
0.05 was considered significant.
The heart rate and blood pressure responses to squatting are
summarized in Table 1. Group 1 subjects had normal left ventric-
ular global and regional function while standing. There were no
WMA while squatting.
In group 2, five patients had a baseline WMA. New or
worseningWMA occurred during squatting in 35 patients. Twelve
patients developed a WMA in the left anterior descending coro-
nary artery territory, five had WMA in the circumflex coronary
artery territory, seven had WMA in the right coronary artery
territory, and seven had normal wall motion. Eleven had WMA in
multiple territories. All WMA resolved on standing within 1 min.
None of these patients developed chest pain, arrhythmias, or
hypotension. The sensitivity, specificity, and accuracy of squatting
echocardiography for diagnosis of the CAD were 92%, 80%, and
91%, respectively. The sensitivity, specificity, and accuracy of
squatting stress echocardiography for the diagnosis of multivessel
CAD were 33%, 92%, and 50%, respectively.
Echocardiograms from a patient in group 1 are depicted in Figure
1, and an example of a patient in group 2 is shown in Figure 2.
Lewis et al. (3) observed that squatting produced an increase in
left ventricular dimension in end-diastole and end-systole. The
heart rate decreased, and blood pressure, stroke index, and cardiac
index increased.
Stress echocardiography performed in conjunction with tread-
mill testing and dobutamine infusion is associated with increases in
heart rate, blood pressure, and contractility. In contrast, squatting
increases myocardial oxygen consumption by augmenting afterload
and preload.
There are some advantages to squatting as a stress test. The
absence of marked changes in heart rate during squatting makes
comparison with the baseline echocardiogram and interpretation
of stress-induced WMA easier than when tachycardia is present.
Ventricular dilatation that occurs with squatting facilitates analysis
of wall motion. The rapid recovery of wall motion after squatting
reduces the risks of adverse sequelae. No ventricular arrhythmias,
chest pain, or hypotension were noted during squatting.
There are some limitations to squatting as a stress test. Patients
with knee or hip disease, or extreme obesity may not be able to
squat. The sonographer also has to squat during the procedure,
and only those with adequate echocardiography windows are
suitable for testing.
The mechanism by which squatting induces WMA is uncertain.
A potential mechanism is unmasking of subclinical segmental
dysfunction in normokinetic segments subtended by stenotic
coronary arteries. Yuda et al. (6) have demonstrated subclinical left
Table 1. Heart Rate and Blood Pressure Data
Standing Squatting p Value
Group 1 (control)
Heart rate (beats/min) 82  16 87  17 0.054
Systolic blood pressure (mm Hg) 131  11 151  11 0.0004
Diastolic blood pressure (mm Hg) 85  10 95  7 0.001
Group 2
Heart rate (beats/min) 80  15 89  15 0.0007
Systolic blood pressure (mm Hg) 126  19 147  24 0.00001
Diastolic blood pressure (mm Hg) 76  13 89  13 0.00001
Figure 1. End-systolic frames during standing (left) and squatting (right) in a normal subject. Note the triangular shape of the apex during standing and
squatting. LV  left ventricle.
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ventricular dysfunction in patients with CAD and normal ejection
fraction. A second potential mechanism is the induction of
myocardial ischemia. Although the absence of angina in our
patients does not support ischemia as a mechanism, it does not
exclude ischemia.
In summary, squatting induces WMA in segments subtended
by coronary artery stenoses. These preliminary data underscore the
potential usefulness of squatting echocardiography as a stress test.
Studies in which squatting is compared with a currently accepted
stress test are needed to assess the value of this novel test.
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Letters to the Editor
Cardiac Medical Therapy Post-Coronary
Bypass Grafting
We read with interest the recent review by Okrainec et al.
entitled, “Cardiac Medical Therapy in Patients After Undergo-
ing Coronary Artery Bypass Graft Surgery” (1). We congratu-
late the investigators on a comprehensive review of this impor-
tant subject. We would, however, like to make a few comments
regarding the use of certain drugs following coronary artery
bypass grafting (CABG). We agree entirely with the researchers
that aspirin and statins should be given to all patients following
surgery, with strong evidence to support this. Okrainec et al. (1)
state that “current data do not support the use of beta-blockers,
calcium channel blockers (CCB), and nitrates, and more evi-
dence is needed regarding the use of angiotensin-converting
enzyme inhibitors (ACEI).”
Although we agree that CCB and nitrates lack data on their use
postbypass surgery, beta-blocker and ACEI use may be warranted
in a wide range of patients post-CABG. In a large cohort of
patients who underwent CABG after myocardial infarction (MI),
beta-blockers reduced one-year mortality from 12% to 4% (2).
Many patients who have undergone CABG but not had an
ST-segment elevation MI are given cardio-selective beta-blockers
postoperatively based on the efficacy of such drugs post-MI;
however, use of such drugs in non–ST-segment elevation MI is
Figure 2. Echocardiogram of a patient in group 2. Left ventricular (LV) function was normal in the standing position. The LV apex had a triangular
appearance at end-systole. An extensive wall motion abnormality developed during squatting (arrows). The distal posterior septum, apex, and distal
posterolateral wall became akinetic, and the distal half of the LV became dilated and circular. The wall motion abnormality and the ventricular shape
normalized on standing.
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